RB

Renier Brentjens

Highly Cited Researcher 2025

Memorial Sloan Kettering Cancer Center

Renier Brentjens is a medical oncologist affiliated with Memorial Sloan Kettering Cancer Center. His research focuses on cellular immunotherapy, including CAR T-cell therapy for hematologic malignancies. He has been involved in developing and evaluating genetically engineered T-cell therapies for cancer.

Field
Medicine · Oncology
Clarivate categories
Cross-Field
Affiliation
Memorial Sloan Kettering Cancer Center, United States